PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

Tributyrin nanoliposomes

Inquiry

Cat. No.: X26-05-ZQ1240

Tributyrin nanoliposomes

Name: Tributyrin nanoliposomes
SKU: X26-05-ZQ1240

Inquiry

Synonym: Tributyrin NLs; Tributyrin liposomes; Tributyrin-loaded nanoliposomes

Product Size

100 mg; 250 mg; 500 mg; 1 g; 5 g

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

This product contains tributyrin nanoliposomes structured to improve the water dispersion and chemical stability of a short-chain triglyceride. The nanoliposome vesicles utilize a fluid-phase phospholipid bilayer that accommodates the hydrophobic glyceride tributyrin within its interior core matrix. This configuration prevents the rapid chemical hydrolysis of the ester bonds by isolating the short-chain fatty acid groups from premature moisture exposure during storage. The resulting nanostructures exhibit a narrow size distribution and a highly uniform spherical morphology.

Source

Custom synthesis

Functional Group

Tributyrin

Form

Solid or powder

Purity

≥95%

Impurities

No visible impurities to the naked eye.

Identity

HPLC/MS/NMR

Publications

Publications (0)

Publications

×

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.